Top compounds associated with response to EML6


Feature Type Standardized
Nominal ANOVA
mRNA linifanib GDSC1000 pan-cancer AAC -0.16 1e-05
mRNA VNLG/124 GDSC1000 pan-cancer AAC -0.15 1e-05
mRNA Nilotinib CCLE pan-cancer AAC -0.22 3e-05
mRNA AZD6244 CTRPv2 pan-cancer AAC -0.15 3e-05
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 4e-05
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.15 4e-05
mRNA PD318088 CTRPv2 pan-cancer AAC -0.14 5e-05
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 5e-05
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 7e-05
mRNA Axitinib GDSC1000 pan-cancer AAC -0.16 7e-05
Download CSV